FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer
FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer The Clinical Trial Vanguard
2026
Salesforce Completes Acquisition of Fin
Salesforce Completes Acquisition of Fin Salesforce